search
Back to results

Prevention of Peritonitis in Peritoneal Dialysis (PEPS)

Primary Purpose

Kidney Failure, Chronic, Peritoneal Dialysis-associated Peritonitis, Dialysis Capd Infection

Status
Completed
Phase
Not Applicable
Locations
Sweden
Study Type
Interventional
Intervention
Follow-up of PD patients´ theoretical and practical skills
Sponsored by
Sahlgrenska University Hospital, Sweden
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Kidney Failure, Chronic focused on measuring Randomized, Peritoneal dialysis, Peritonitis, Primary prevention, Quality control, Self care, Kidney failure, chronic

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patient is able to perform PD without assistance
  • Age 18 years old or more

Exclusion Criteria:

  • Previous PD-treatment less than 2 years ago
  • Peritonitis before inclusion
  • Active malignancy
  • Participation in other studies during the study period which may affect outcome of the present study

Sites / Locations

  • Department of Nephrology, Sahlgrenska University Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

The follow-up group

Control group

Arm Description

The intervention in the follow-up group consists of regular tests of the patients´ theoretical and practical skills regarding peritoneal dialysis. The test goals should be passed. If not, retraining will be given if needed til the goals are reached. The peritonitis rate in this group will be compared with that of the control group.

Patients randomised to the control group will be treated according to the routines of the clinic.

Outcomes

Primary Outcome Measures

The incidence of peritonitis during the whole study and the peritonitis-free survival both during the first 12 months after PD start and during the whole study wil be compared in the two groups.
The time to first peritonitis episode will be analysed as the cumulative time without peritonitis using the Cox regression model for mulivariate analyses. Log rank test will be used to compare the groups. Actuarial survival curves showing the proportions of peritonitis free patients over time in the two groups will be determined using the Kaplan-Meier life table method. Analysis will be sensored at death and kidney transplantation.

Secondary Outcome Measures

Risk factors for peritonitis
The impact of age, sex, type of kidney disease, co-morbidity, physical handicap, and type of peritoneal dialysis on the risk of development of peritonitis will be studied
Days of hospitalization due to peritonitis
The number of hospitalization days due to peritonitis in the two groups will be compared.

Full Information

First Posted
February 10, 2011
Last Updated
September 11, 2019
Sponsor
Sahlgrenska University Hospital, Sweden
Collaborators
Odense University Hospital, Rigshospitalet, Denmark, Central Hospital HF, Lillehammer, Norway (dr Dag Paulsen), Tampere University Hospital, Pauls Stradins Clinical University Hospital, Tartu University Hospital, Tartu, Estonia (dr Mai Rosenberg), Karolinska Institutet, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), Sheffield Teaching Hospitals NHS Foundation Trust
search

1. Study Identification

Unique Protocol Identification Number
NCT01293799
Brief Title
Prevention of Peritonitis in Peritoneal Dialysis
Acronym
PEPS
Official Title
Prevention of Peritonitis in Patients With Peritoneal Dialysis - Effects of Regular Follow-up of Patients´ Theoretical Knowledge and Practical Skills With Focus on Infection Prophylaxis
Study Type
Interventional

2. Study Status

Record Verification Date
May 2019
Overall Recruitment Status
Completed
Study Start Date
January 2010 (undefined)
Primary Completion Date
December 2012 (Actual)
Study Completion Date
December 31, 2015 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Sahlgrenska University Hospital, Sweden
Collaborators
Odense University Hospital, Rigshospitalet, Denmark, Central Hospital HF, Lillehammer, Norway (dr Dag Paulsen), Tampere University Hospital, Pauls Stradins Clinical University Hospital, Tartu University Hospital, Tartu, Estonia (dr Mai Rosenberg), Karolinska Institutet, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), Sheffield Teaching Hospitals NHS Foundation Trust

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
BACKGROUND: Peritonitis remains a significant problem in peritoneal dialysis. It is the leading cause of technique failure, and contributes to mortality. The incidence is highest during the first year of treatment. Non-compliance with the Peritoneal Dialysis (PD) protocol is shown to be an important risk factor for peritonitis. Reinforcement of knowledge and ability to perform PD therefore appears to be a possible way to reduce the incidence of peritonitis. This will be studied in The PEritonitis Prevention Study (PEPS). METHODS: The objective of this randomized, multi-centre investigation,which will include 750 new PD patients who can perform (PD) without assistance, is to evaluate if regular retraining can reduce the incidence of peritonitis, the technique-failure rate, and the hospitalisation days due to peritonitis compared with regular follow-up regimen. Patients in the intervention group will tested by a PD-technique test and a questionnaire at regular intervals after PD-start and after every peritonitis episode with focus on infection prophylaxis. If needed, they will be retrained. The control group will be treated according to the routine of the center. The study is ongoing in Denmark, Norway, Sweden, Finland, Estonia, Latvia, the Netherlands, and the UK. The study will go on for 6 years.
Detailed Description
BACKGROUND See above. AIMS To study if regular follow-up of PD patients with testing of their theoretical and practical knowledge (hereafter called "new type of follow-up") can reduce the incidence of peritonitis, reduce the technique failure rate related to peritonitis, and reduce the time of hospitalization related to peritonitis compared to a routine regimen. For specific aims, see "Outcome measures" below. PATIENTS AND METHODS The study is a randomized, multi-centre investigation intending to enclose 750 new PD patients in Sweden, Denmark, Norway, Finland, Estonia, Latvia, the Netherlands, and the United Kingdom. Inclsuion was finished on December 31, 2014. The study will go on until the last included patient has taken part of the study for one year. The study will thus be terminated on December 31, 2015. The study includes a follow-up group and a control group. The intervention in the follow-up group consists of regular testing of theoretical and practical knowledge regarding PD with focus on infection prophylaxis including retraining if needed until the test goals are reached. The control group will be treated according to the routines of the center. Peritonitis is defined according to ISPD guidelines (Perit Dial Int 2005;25:107-131) The baseline PD training will be the same at all participating centres and follow international recommendations. In addition, fluorescent alcohol and a UV lamp will be used to control the result of hand disinfection in all patients once during the initial PD training. Thereafter this method will only be used in the follow-up group. In the follow-up group, the knowledge from the basal training will be tested at 1, 3, 6, and 12 months after PD start, every sixth month thereafter, and after every episode of peritonitis. Such testing will also be performed at restart of PD. The follow-up includes two types of tests: The patient will fill in a questionnaire with theoretical and practical questions with focus on infection and infection prophylaxis during PD treatment. Goal: At least 80% of the questions should be correct. If the goal is not reached, further training will be given until the goal is reached. The patient will perform a practical test including hand disinfection, PD exchange technique, and exit-site care. Hand disinfection skills will be controlled with the help of fluorescent alcohol and a UV lamp. Goal: All steps of the practical test should be correctly performed. If not, further training will be given until the goal is reached.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Kidney Failure, Chronic, Peritoneal Dialysis-associated Peritonitis, Dialysis Capd Infection
Keywords
Randomized, Peritoneal dialysis, Peritonitis, Primary prevention, Quality control, Self care, Kidney failure, chronic

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
713 (Actual)

8. Arms, Groups, and Interventions

Arm Title
The follow-up group
Arm Type
Experimental
Arm Description
The intervention in the follow-up group consists of regular tests of the patients´ theoretical and practical skills regarding peritoneal dialysis. The test goals should be passed. If not, retraining will be given if needed til the goals are reached. The peritonitis rate in this group will be compared with that of the control group.
Arm Title
Control group
Arm Type
No Intervention
Arm Description
Patients randomised to the control group will be treated according to the routines of the clinic.
Intervention Type
Behavioral
Intervention Name(s)
Follow-up of PD patients´ theoretical and practical skills
Intervention Description
Testing of patients knowledge and retraining if needed
Primary Outcome Measure Information:
Title
The incidence of peritonitis during the whole study and the peritonitis-free survival both during the first 12 months after PD start and during the whole study wil be compared in the two groups.
Description
The time to first peritonitis episode will be analysed as the cumulative time without peritonitis using the Cox regression model for mulivariate analyses. Log rank test will be used to compare the groups. Actuarial survival curves showing the proportions of peritonitis free patients over time in the two groups will be determined using the Kaplan-Meier life table method. Analysis will be sensored at death and kidney transplantation.
Time Frame
From PD start to either 12 months after PD start or to the whole study
Secondary Outcome Measure Information:
Title
Risk factors for peritonitis
Description
The impact of age, sex, type of kidney disease, co-morbidity, physical handicap, and type of peritoneal dialysis on the risk of development of peritonitis will be studied
Time Frame
During the complete follow-up, i.e. from the day the first patient is included to one year after the last patient is included. The study will stop at a certain date
Title
Days of hospitalization due to peritonitis
Description
The number of hospitalization days due to peritonitis in the two groups will be compared.
Time Frame
During the complete follow-up, i.e. from the day the first patient is included to one year after the last patient is included. The study will stop at a certain date

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patient is able to perform PD without assistance Age 18 years old or more Exclusion Criteria: Previous PD-treatment less than 2 years ago Peritonitis before inclusion Active malignancy Participation in other studies during the study period which may affect outcome of the present study
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Susanne Ljungman, Prof.
Organizational Affiliation
Department of Nephrology, Sahlgrenska University Hospital, Gothenburg, Sweden
Official's Role
Study Director
Facility Information:
Facility Name
Department of Nephrology, Sahlgrenska University Hospital
City
Gothenburg
ZIP/Postal Code
SE-413 45
Country
Sweden

12. IPD Sharing Statement

Learn more about this trial

Prevention of Peritonitis in Peritoneal Dialysis

We'll reach out to this number within 24 hrs